Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia.

Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia.

Item
http://www.wikidata.org/entity/Q45990981
Lipid-lowering efficacy of rosuvastatinDoes combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?High density lipoproteins and type 2 diabetes: Emerging concepts in their relationship.Lipoprotein subfraction cholesterol distribution is proatherogenic in women with type 1 diabetes and insulin resistance.Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatmentEffects of lipid-lowering drugs on high-density lipoprotein subclasses in healthy men-a randomized trial.The Pleiotropic Effects of Atorvastatin on Stable Angina Patients: Evidence by Analysis of High-Density Lipoprotein Size and Subclasses, and Plasma mRNA.High density lipoprotein and cardiovascular diseases.Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies.Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables.Combining rosuvastatin with angiotensin-receptor blockers of different PPARγ-activating capacity: effects on high-density lipoprotein subfractions and associated enzymes.
P2860

Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia.

Item
http://www.wikidata.org/entity/Q45990981
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Dose-dependent effect of rosuv ...... s with primary hyperlipidemia.
@en
Dose-dependent effect of rosuv ...... s with primary hyperlipidemia.
@nl
type
label
Dose-dependent effect of rosuv ...... s with primary hyperlipidemia.
@en
Dose-dependent effect of rosuv ...... s with primary hyperlipidemia.
@nl
prefLabel
Dose-dependent effect of rosuv ...... s with primary hyperlipidemia.
@en
Dose-dependent effect of rosuv ...... s with primary hyperlipidemia.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Dose-dependent effect of rosuv ...... ts with primary hyperlipidemia
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921